Milla Pietiäinen

Dr. Milla Pietiäinen

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2018 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
PDF file
LLLaura S. J. Lahdentausta
Laura S. J. Lahdentausta
SPSusanna Paju
Susanna Paju
PMPäivi Mäntylä
Päivi Mäntylä
KBKåre Buhlin
Kåre Buhlin
TTTaina Tervahartiala
Taina Tervahartiala
PPPirkko J. Pussinen
Pirkko J. Pussinen

3 December 2019 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
PDF file
MÖMeltem Özdemir
Meltem Özdemir
FCFeriha Caglayan
Feriha Caglayan
FBFloris Bikker
Floris Bikker
PPPirkko Pussinen
Pirkko Pussinen
EKEija Könönen
Eija Könönen
UGUlvi Kahraman Gursoy
Ulvi Kahraman Gursoy

31 January 2018 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
PDF file
MPMilla Pietiäinen
Milla Pietiäinen
KKK. A. Elisa Kopra
K. A. Elisa Kopra
JVJuha Vuorenkoski
Juha Vuorenkoski
ASAino Salminen
Aino Salminen
SPSusanna Paju
Susanna Paju
PPPirkko Pussinen
Pirkko Pussinen

24 December 2021 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
EKElisa Kopra
Elisa Kopra
LLLaura Lahdentausta
Laura Lahdentausta
MPMilla Pietiäinen
Milla Pietiäinen
KBKåre Buhlin
Kåre Buhlin
PMPäivi Mäntylä
Päivi Mäntylä
PPPirkko Pussinen
Pirkko Pussinen
The use of systemic antibiotics may influence the oral microbiota composition. Our aim was to investigate in this retrospective study whether the use of prescribed antibiotics associate with periodontal status, oral microbiota, and antibodies against the periodontal pathogens. The Social Insurance Institution of Finland Data provided the data on the use of systemic antibiotics by record linkage to purchased medications and entitled reimbursements up to 1 year before the oral examination and sampling. Six different classes of antibiotics were considered. The Parogene cohort included 505 subjects undergoing coronary angiography with the mean (SD) age of 63.4 (9.2) years and 65% of males. Subgingival plaque samples were analysed using the checkerboard DNA-DNA hybridisation. Serum and saliva antibody levels to periodontal pathogens were analysed with immunoassays and lipopolysaccharide (LPS) activity with the LAL assay. Systemic antibiotics were prescribed for 261 (51.7%) patients during the preceding year. The mean number of prescriptions among them was 2.13 (range 1–12), and 29.4% of the prescriptions were cephalosporins, 25.7% penicillins, 14.3% quinolones, 12.7% macrolides or lincomycin, 12.0% tetracycline, and 5.8% trimethoprim or sulphonamides. In linear regression models adjusted for age, sex, current smoking, and diabetes, number of antibiotic courses associated significantly with low periodontal inflammation burden index (PIBI, p < 0.001), bleeding on probing (BOP, p = 0.006), and alveolar bone loss (ABL, p = 0.042). Cephalosporins associated with all the parameters. The phyla mainly affected by the antibiotics were Bacteroidetes and Spirochaetes. Their levels were inversely associated with the number of prescriptions (p = 0.010 and p < 0.001) and directly associated with the time since the last prescription (p = 0.019 and p < 0.001). Significant inverse associations were observed between the number of prescriptions and saliva concentrations of Prevotella intermedia, Tannerella forsythia, and Treponema denticola and subgingival bacterial amounts of Porphyromonas gingivalis, P. intermedia, T. forsythia, and T. denticola. Saliva or serum antibody levels did not present an association with the use of antibiotics. Both serum (p = 0.031) and saliva (p = 0.032) LPS activity was lower in patients having any antibiotic course less than 1 month before sampling. Systemic antibiotics have effects on periodontal inflammation and oral microbiota composition, whereas the effects on host immune responses against the periodontal biomarker species seem unchanged.

22 March 2024 in Journal of Oral Microbiology
Verified
Journal Article
Open access
MMMUHAMMED MANZOOR
MUHAMMED MANZOOR
JLJaakko Leskelä
Jaakko Leskelä
MPMilla Pietiäinen
Milla Pietiäinen
NMNicolas Nicolas Martinez-Majander
Nicolas Nicolas Martinez-Majander
EKEija Könönen
Eija Könönen
SPSusanna Paju
Susanna Paju
Gingivitis, i.e. inflammation of the gums, is often induced by dentalplaque. However, its exact link to the oral microbiota remains unclear. In a case-control study involving 120 participants, comprising 60 cases and 60 controls (mean age (SD) 36.6 (7.6) years; 50% males), nested within a prospective multicentre cohort study, we examined theoral microbiome composition of gingivitis patients and their controlsusing shotgun metagenomic sequencing of saliva samples. Participants underwent clinical and radiographic oral health examinations, including bleeding on probing (BOP), at six tooth sites. BOP ≥33%was considered ‘generalized gingivitis/initial periodontitis’(GG/IP), and BOP <33% as ‘healthy and localized gingivitis’(H/LG). Functional potential was inferred using HUMANn3. GG/IP exhibited an increase in the abundance of Actinomyces, Porphyromonas, Aggregatibacter, Corynebacterium, Olsenella, and Treponema, whereas H/LG exhibited an increased abundance of Candidatus Nanosynbacter. Nineteen bacterial species and fourmicrobial functional profiles, including L-methionine, glycogen, andinosine-5’-phosphate biosynthesis, were associated with GG/IP. Constructing models with multiple markers resulted in a strong predictive value for GG/IP, with an area under the curve (ROC) of 0.907 (95% CI: 0.848-0.966). We observed distinct differences in the oral microbiome between the GG/IP and H/LG groups, indicating similar yet unique microbial profiles and emphasizing their potential role in progression of periodontal diseases.

Verified
Journal Article
Open access
PDF file
MPMilla Pietiäinen
Milla Pietiäinen
JLJohn M. Liljestrand
John M. Liljestrand
RARamin Akhi
Ramin Akhi
KBKåre Buhlin
Kåre Buhlin
Anders JohanssonAnders Johansson
Anders Johansson
PPPirkko Pussinen
Pirkko Pussinen
Apical periodontitis is an inflammatory reaction at the apex of an infected tooth. Its microbiota resembles that of marginal periodontitis and may induce local and systemic antibodies binding to bacteria- and host-derived epitopes. Our aim was to investigate the features of the adaptive immune response in apical periodontitis. The present Parogene cohort (n = 453) comprises patients with cardiac symptoms. Clinical and radiographic oral examination was performed to diagnose apical and marginal periodontitis. A three-category endodontic lesion score was designed. Antibodies binding to the bacteria- and host-derived epitopes were determined from saliva and serum, and bacterial compositions were examined from saliva and subgingival samples. The significant ORs (95% CI) for the highest endodontic scores were observed for saliva IgA and IgG to bacterial antigens (2.90 (1.01–8.33) and 4.91 (2.48–9.71)/log10 unit), saliva cross-reacting IgG (2.10 (1.48–2.97)), serum IgG to bacterial antigens (4.66 (1.22–10.1)), and Gram-negative subgingival species (1.98 (1.16–3.37)). In a subgroup without marginal periodontitis, only saliva IgG against bacterial antigens associated with untreated apical periodontitis (4.77 (1.05–21.7)). Apical periodontitis associates with versatile adaptive immune responses against both bacterial- and host-derived epitopes independently of marginal periodontitis. Saliva immunoglobulins could be useful biomarkers of oral infections including apical periodontitis—a putative risk factor for systemic diseases.